Into the Flow #2: AKI Prevention with RenalGuard
This week’s episode is a follow-up from a previous episode published back in February called ‘Into the Flow: AKI Prevention with RenalGuard’, which centered around RenalGuard and the ability to prevent Acute Kidney Injury (AKI) through its use in percutaneous interventions. For part two, we are exploring the use of RenalGuard in cardiac surgery and how implementing this device translates to improved patient outcomes and management.
Joining the podcast this time is Dr Heyman Luckraz, Cardiothoracic Surgeon, American Hospital, Dubai, United Arab Emirates, who has studied the use of RenalGuard to reduce AKI in cardiac surgery patients in a randomized controlled trial. The incidence of cardiac surgery associated AKI is around 30%, and Dr Luckraz will be discussing the findings of ICU and hospital stays, touching on long-term renal follow-up, and quality of life amongst other topics. This podcast is supported by a grant from KANEKA Medical.